Topics

Gliomas | Treatment | Chemotherapy | Temozolomide

Home > Publications > Topics > Gliomas > Treatment > Chemotherapy > Temozolomide

Li H, Wu Y, Chen Y, Lv J, Qu C, Mei T, Zheng Y, Ye C, Li F, Ge S, Yao A, Jia L.
Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights.
Acta Neuropathol Commun. 2025 Jun 5;13(1):126. doi: 10.1186/s40478-025-02046-4. PMID: 40468460. Review. ˍ

Yogendran LV, Kareddy A, Abbas SO, Scharf Z, Patrie J, Patel SH, Schiff D.
Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression.
J Neurooncol. 2025 Aug 20. doi: 10.1007/s11060-025-05087-w. PMID: 40836201. Observational study. ˍ AI Overv

Yaacov A, Gillis R, Salim J, Katz D, Asna N, Paldor I, Grinshpun A.
The Temozolomide Mutational Signature: Mechanisms, Clinical Implications, and Therapeutic Opportunities in Primary Brain Tumor Management.
Cells. 2025 Dec 29;15(1):57. doi: 10.3390/cells15010057. PMID: 41511341. Review. ˍ